VENUSREMNSEVenus Remedies Limited· PharmaceuticalsMediumNeutral
Announced Tue, 26 May · 22:19 IST

Venus Remedies Limited has informed the Exchange that Record date for the purpose of Dividend is 07-Aug-2026.

Corporate Actions View source PDF

VENUSREM · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+10.3%1-day move
₹1160.00
prior close
₹1219.10
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.0+0.0+0.0+0.0+10.3+15.9+21.7+27.7+34.1+41.9+48.5+66.3+35.6
Up moveDown movePending
AI summary

Venus Remedies Limited has announced a final dividend of Rs. 10 per share (100% on face value of Rs. 10) for FY2025-26, subject to shareholder approval at the 37th AGM on August 20, 2026. The record date to determine eligible shareholders is August 7, 2026. For Q4 FY2026, standalone net profit rose to Rs. 43.45 crore (vs Rs. 14.79 crore in Q4 FY2025), while full-year standalone net profit surged 89% to Rs. 99.31 crore from Rs. 52.55 crore. Consolidated net profit for FY2026 reached Rs. 102.78 crore, nearly doubling from Rs. 45.31 crore. Revenue from operations grew 19% year-on-year to Rs. 768.73 crore on standalone basis. The company also announced appointments/reappointments of independent directors and adoption of new MOA/AOA aligned with Companies Act 2013.

Likely market impact

Strong financial performance with near-doubling of net profit and consistent dividend declaration signals company health and shareholder returns, which could be positive for the stock.